Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Insys Therapeutics revenue
Insys Therapeutics's revenue is $146.6 million.
What is Insys Therapeutics's revenue?
- Insys Therapeutics has 343 employees, and the revenue per employee ratio is $427,405.
- Insys Therapeutics peak revenue was $146.6M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Insys Therapeutics financing
Insys Therapeutics received early financing of $2.3M on 2011-03-28.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $2.3M | 03/2011 |
Insys Therapeutics competitors
Insys Therapeutics's top competitor, Merck, earned an annual revenue of $64.2B.
Insys Therapeutics's smallest competitor is PDI with revenue of $22.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Amneal Pharmaceuticals | $76,227 | $2.8B | 6,500 | 97 |
| Merck | $90,328 | $64.2B | 74,000 | 1,556 |
| Quidel | $71,489 | $1.7B | 1,500 | - |
| Seagen | $85,008 | $2.0B | 900 | - |
| Amgen | $93,349 | $33.4B | 22,000 | 576 |
| Regeneron | $85,589 | $14.2B | 9,123 | 369 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 613 |
| Neurocrine Biosciences | $78,232 | $2.4B | 400 | 430 |
| Paddock Laboratories | $69,519 | $100.5M | 51 | - |
| Shionogi | $78,066 | $50.0M | 6,082 | 82 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Insys Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Insys Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Insys Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Insys Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Insys Therapeutics. The data presented on this page does not represent the view of Insys Therapeutics and its employees or that of Zippia.
Insys Therapeutics may also be known as or be related to INSYS THERAPEUTICS INC., INSYS Therapeutics Inc, INSYS Therapeutics, Inc., Insys RX, Insys Therapeutics, Insys Therapeutics Inc. and Insys Therapeutics, Inc.